Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer

Fig. 7

The expression levels and prognostic value of IGF2BP3. A The comparison of IGF2BP3 expression levels between the tumor and normal tissues. B IGF2BP3 expression levels in different tumor cell lines from the Cancer Cell Line Encyclopedia (CCLE) database. C The correlation between the programmed cell death ligand 1 (PD-L1) and IGF2BP3 mRNA expression levels from the CCLE database. D IGF2BP3 expression levels in the Oncomine database. P value threshold was set 0.05 and the fold-change threshold was set 2.0. The number in the colored cells represents the number of studies meeting the thresholds. The printed red (over-expression) or blue colors (under-expression) indicate a significant association. E The relation of IGF2BP3 with PD-L1 from the TIMER website. F The Kaplan–Meier curve shows the prognostic values of IGF2BP3 in patients with BCa obtained via Gene Expression Profiling Interactive Analysis (GEPIA), which was based on TCGA database. G, H The anatomical structure showed the expression levels of the IGF2BP3 in the normal organ tissues in males (G) and females (H). I Histogram visualizing the expression levels of IGF2BP3 in normal organ tissues. J Histogram visualizing the expression levels of IGF2BP3 in normal organ tissues between the females and males. *P < 0.05, ***P < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us